Tesamorelin (off-label)
- Evidence
- Moderate research
- Class
- GHRH analog
Tesamorelin (off-label) belongs to the GHRH analog class. This library groups it under hormones & metabolism. Its source category is Not FDA-approved.
At a glance
| Compound class | GHRH analog |
|---|---|
| Associated brands | Egrifta (approved) |
| Body system | Hormones & metabolism |
| Use or research focus | Body composition (off-label) |
| Regulatory status | Approved (Egrifta); used off-label in wellness |
| Source evidence rating | Moderate research |
How does Tesamorelin (off-label) work?
GH secretagogue.
The source catalog maps this mechanism to Pituitary, Adipose / Fat, Muscle. A biological mechanism describes how a compound interacts with the body; it does not by itself prove a clinical benefit.
What does the evidence tell us?
The source catalog describes an intermediate evidence base. Early clinical findings may leave questions about effectiveness, dose, interactions, and long-term safety. Read the individual studies before drawing conclusions about a specific use.
Use the Citations tab to examine the underlying sources. Look for human studies, a relevant comparison group, meaningful outcomes, and adequate follow-up. An ingredient, approved drug, and compounded preparation may have different evidence.
Safety and considerations
For an unapproved use or compound, safety and effectiveness may be uncertain. Products sold for research are not a substitute for prescribed care. Do not infer a human dose, injection protocol, or treatment recommendation from preclinical research.
This library is educational and does not provide dosing or treatment instructions. A listing here does not indicate that Peppy offers the compound.
Common questions
What is Tesamorelin (off-label)?
Tesamorelin (off-label) belongs to the GHRH analog class. This library groups it under hormones & metabolism. Its source category is Not FDA-approved. Its recorded use or research focus is: Body composition (off-label).
Is Tesamorelin (off-label) FDA-approved?
The catalog records: Approved (Egrifta); used off-label in wellness. Check the current product-specific regulatory information in the source links; a source category does not establish approval for every use or formulation.
How strong is the research?
The source catalog describes an intermediate evidence base. Early clinical findings may leave questions about effectiveness, dose, interactions, and long-term safety. Read the individual studies before drawing conclusions about a specific use.
Where can I read the research?
The Citations tab contains 0 reference links from the source dataset. The original research guide provides additional context. These links are a starting point for reading the evidence.
More for hormones & metabolism
Factual catalog fields and citation links are adapted from Superpower’s Tesamorelin (off-label) guide and the public dataset linked in the reference post. Peppy’s explanations are educational; this page does not represent an independent clinical review of every linked study.
Sources & further reading
References associated with Tesamorelin (off-label) in the source dataset. Open a source to review its study design, population, limitations, and date.
The imported dataset does not list individual citations for this entry. Read the source guide for its context.
View the original research guide